CoChat
Sign Up
Cited by 11Dialysis and Renal Disease ManagementCentral Venous Catheters and HemodialysisParathyroid Disorders and Treatments

Patient-Centered Care Could Improve Quality of Life and Survival of Dialysis Patients: Dialysis Prescription and Daily Practice

Open access
Masakane, Ikuto, Ito, Minoru, Tanida, Hideki, Nawano, Takaaki·2023·Blood Purification
DOI 10.1159/000526995PMC PMC10210077
Open this paper in CoChat — free account

Abstract

We now face a paradigm shift in clinical practice and research of dialysis from evidence-based medicine outcomes to patient-reported outcomes (PROs). It is imperative to establish a daily practice pattern based on the PROs, namely “patient-centered dialysis care.” In 2005, we introduced the concept of “patient-oriented dialysis,” which includes two fundamental components; adjustment of the dialysis prescription according to the PROs and nutritional intervention based on the global nutritional assessment. Routine examinations and team meetings were held to monitor the status of PROs and nutrition, and intervention plans were reevaluated. We found that the total score of the PROs was closely related to the survival rate of dialysis patients, and some of those were identified as independent mortality risk factors. These results might have shown that patient-centered dialysis care may improve the quality of life and the survival rate of dialysis patients. Polymethyl methacrylate (PMMA) is a unique synthetic membrane for a dialyzer with protein adsorption property and biocompatibility. Several clinical advantages of PMMA were reported as ameliorating inflammatory status, nutritional status, skin itchiness, and dialysis-related fatigue. PMMA is a fundamental and major choice for improving PROs in patient-centered dialysis care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000526995

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The persistence of hypervolemia in 94.1% of the control group may justify the marked deterioration in the quality of hemodialysis in these patients, since excess fluid volume directly affects the quality of dialysis in patients with chronic kidney disease.

    “The persistence of hypervolemia in 94.1% of the CG may justify the marked deterioration in the quality of hemodialysis in these patients, since EFV directly affects the quality of dialysis in patients with chronic kidney disease.28”

    From Effect of the fluid management nursing intervention on improving biochemical test results and dialysis therapy in chronic kidney disease patients: a randomized controlled trial (2025) · cites this paper as [28]

    Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

  • Hypervolemia directly affects the quality of dialysis, and its elimination contributed to more effective dialysis.

    “Hypervolemia directly affects the quality of dialysis, and its elimination contributed to more effective dialysis.”

    From Effect of the fluid management nursing intervention on improving biochemical test results and dialysis therapy in chronic kidney disease patients: a randomized controlled trial (2025) · cites this paper as [28]

    The Dialysis Quality Evaluation section discusses dialysis quality in terms of solute removal, biocompatibility, and patient-reported outcomes, not hypervolemia. Searches for hypervolemia, fluid overload, volume status, and fluid removal found no passage saying that eliminating hypervolemia made dialysis more effective. Page numbers were unavailable in our copy. (LLM, conf=0.74)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. [1]Ronco C La Manna G. Expanded hemodialysis a new therapy for a new class of membranes Contrib Nephrol 2017 190 124 133 28535525
  2. [3]Nissenson AR Improving outcomes for ESRD patients shifting the quality paradigm Clin J Am Soc Nephrol 2014 Feb 9 (2) 430 434 24202130 PMC3913244
  3. [4]Aucella F Vigilante M Gesuete A Maruccio G Specchio A Gesualdo L Uraemic itching do polymethylmethacrylate dialysis membranes play a role? Nephrol Dial Transplant 2007 Jul 22 (Suppl 5) v8 v12 17586845
  4. [6]Galli F Benedetti S Floridi A Canestrari F Piroddi M Buoncristiani E Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers Kidney Int 2005 Feb 67 (2) 750 759 15673326
  5. [7]Barry MJ Edgman-Levitan S Shared decision making pinnacle of patient-centered care N Engl J Med 2012 Mar 1 366 (9) 780 781 22375967
  6. [8]Tong A Manns B Wang AYM Hemmelgarn B Wheeler DC Gill J Implementing core outcomes in kidney disease report of the Standardized Outcomes in Nephrology (SONG) implementation workshop Kidney Int 2018 Dec 94 (6) 1053 1068 30360959 PMC6620755
  7. [9]Lodebo BT Shah A Kopple JD Is it important to prevent and treat protein-energy wasting in chronic kidney disease and chronic dialysis patients? J Ren Nutr 2018 Nov 28 (6) 369 379 30057212
  8. [10]Stenvinkel P Heimburger O Paultre F Diczfalusy U Wang T Berglund L Strong association between malnutrition and atherosclerosis in chronic renal failure Kidney Int 1999 May 55 (5) 1899 1911 10231453
  9. [11]Fouque D Kalantar-Zadeh K Kopple J Cano N Chauveau P Cuppari L A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease Kidney Int 2008 Feb 73 (4) 391 398 18094682
  10. [12]Masakane I High-quality dialysis a lesson from the Japanese experience: effects of membrane material on nutritional status and dialysis-related symptoms NDT Plus 2010 May 3 (Suppl 1) i28 i35 27046011 PMC4813821
  11. [13]Masakane I Choice of modality with the use of high-performance membrane and evaluation for clinical effects Contrib Nephrol 2011 173 84 94 21865780
  12. [14]Masakane I Sakurai K Current approaches to middle molecule removal room for innovation Nephrol Dial Transplant 2018 Oct 1 33 (Suppl 3) iii12 iii21 30281129 PMC6168896
  13. [15]Ito M Nawano T Masakane I Yamaguchi I Kudo K Nagasawa J Clinical impact of patient-centered care for hemodialysis patients using routine assessment of symptom burden Ther Apher Dial 2022 26 (2) 417 424 34190410
  14. [16]Sakurai K Biomarkers for evaluation of clinical outcomes of hemodiafiltration Blood Purif 2013 35 (Suppl 1) 64 68 23466382
  15. [17]Kalantar-Zadeh K Kopple JD Block G Humphreys MH A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients Am J Kidney Dis 2001 Dec 38 (6) 1251 1263 11728958
  16. [18]Kalantar-Zadeh K Kleiner M Dunne E Lee GH Luft FC A modified quantitative subjective global assessment of nutrition for dialysis patients Nephrol Dial Transplant 1999 Jul 14 (7) 1732 1738 10435884
  17. [19]Borges MCC Vogt BP Martin LC Caramori JCT Malnutrition inflammation score cut-off predicting mortality in maintenance hemodialysis patients Clin Nutr ESPEN 2017 Feb 17 63 67 28361749
  18. [20]Rayner HC Zepel L Fuller DS Morgenstern H Karaboyas A Culleton BF Recovery time quality of life and mortality in hemodialysis patients the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 2014 Jul 64 (1) 86 94 24529994 PMC4069238
  19. [21]Lindsay RM Heidenheim PA Nesrallah G Garg AX Suri R Daily Hemodialysis Study Group London Health Sciences Centre. Minutes to recovery after a hemodialysis session a simple health-related quality of life question that is reliable, valid, and sensitive to change Clin J Am Soc Nephrol 2006 Sep 1 (5) 952 959 17699312
  20. [22]Bolton S Gair R Nilsson LG Matthews M Stewart L McCullagh N Clinical assessment of dialysis recovery time and symptom burden impact of switching hemodialysis therapy mode Patient Relat Outcome Meas 2021 12 315 321 34764715 PMC8575372
  21. [23]Narita I Iguchi S Omori K Gejyo F Uremic pruritus in chronic hemodialysis patients J Nephrol 2008 Mar-Apr 21 (2) 161 165 18446709
  22. [24]Kandi M Brignardello-Petersen R Couban R Wu C Nesrallah G Clinical outcomes with medium cut-off versus high-flux hemodialysis membranes a systematic review and meta-analysis Can J Kidney Health Dis 2022 9 20543581211067087 35083060 PMC8785433
  23. [25]Blankestijn PJ Fischer KI Barth C Cromm K Canaud B Davenport A Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol BMJ Open 2020 Feb 5 10 (2) e033228 PMC7044930 32029487
  24. [26]Bacelar Marques ID Pinheiro KF de Freitas do Carmo LP Costa MC Abensur H Anaphylactic reaction induced by a polysulfone/polyvinylpyrrolidone membrane in the 10th session of hemodialysis with the same dialyzer Hemodial Int 2011 Jul 15 (3) 399 403 21624039
  25. [27]Daugirdas JT Bernardo AA Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia Kidney Int 2012 Jul 82 (2) 147 157 22592187
  26. [28]Bosch-Panadero E Mas S Sanchez-Ospina D Camarero V Perez-Gomez MV Saez-Calero I The choice of hemodialysis membrane affects bisphenol A levels in blood J Am Soc Nephrol 2016 May 27 (5) 1566 1574 26432902 PMC4849825
  27. [29]Oshihara W Fujieda H Ueno Y A new poly(methyl methacrylate) membrane dialyzer, NF, with adsorptive and antithrombotic properties Contrib Nephrol 2017 189 230 236 27951573
  28. [30]Yamada S Kataoka H Kobayashi H Ono T Minakuchi J Kawano Y Identification of an erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F) Contrib Nephrol 1999 125 159 172 9895438
  29. [31]Aucella F Vigilante M Gesuete A Review the effect of polymethylmethacrylate dialysis membranes on uraemic pruritus NDT Plus 2010 May 3 (Suppl 1) i8 i11 27045813 PMC4813819
  30. [32]Contin-Bordes C Lacraz A de Precigout V Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients new findings of its amelioration using polymethylmethacrylate (PMMA) membrane NDT Plus 2010 May 3 (Suppl 1) i20 i27 27045744 PMC4813818
  31. [33]Stasi A Franzin R Divella C Sallustio F Curci C Picerno A PMMA-based continuous hemofiltration modulated complement activation and renal dysfunction in LPS-induced acute kidney injury Front Immunol 2021 12 605212 33868226 PMC8047323
  32. [35]Abe M Hamano T Wada A Nakai S Masakane I High-performance membrane dialyzers and mortality in hemodialysis patients a 2-year cohort study from the annual survey of the Japanese renal data registry Am J Nephrol 2017 46 (1) 82 92 28675885
  33. [36]Narita I Alchi B Omori K Sato F Ajiro J Saga D Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients Kidney Int 2006 May 69 (9) 1626 1632 16672924
  34. [37]Pisoni RL Wikstrom B Elder SJ Akizawa T Asano Y Keen ML Pruritus in haemodialysis patients International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 2006 Dec 21 (12) 3495 3505 16968725
  35. [38]Aucella F Gesuete A Vigilante M Prencipe M Adsorption dialysis from physical principles to clinical applications Blood Purif 2013 35 (Suppl 2) 42 47 23676835
  36. [40]Sklar AH Beezhold DH Newman N Hendrickson T Dreisbach AW Postdialysis fatigue lack of effect of a biocompatible membrane Am J Kidney Dis 1998 Jun 31 (6) 1007 1010 9631846
  37. [42]Kikuchi K Hamano T Wada A Nakai S Masakane I Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis Kidney Int 2019 Apr 95 (4) 929 938 30782421
  38. [43]Maduell F Broseta JJ Rodriguez-Espinosa D Hermida-Lama E Rodas LM Gomez M Evaluation and comparison of polysulfone TS-UL and PMMA NF-U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration Artif Organs 2021 Sep 45 (9) E317 E23 33908062

Cited by

Sorted by citations

Authors
Masakane, I., Ito, M., Tanida, H., & Nawano, T.
Affiliations
Yamagata University (JP)
Corresponding author
Masakane, Ikuto
ORCID
Venue
Blood Purification
Publisher
S. Karger AG
Published
2023-01-26
Volume
52
Issue
Suppl. 1
Pages
15-26
ISSN
  • 0253-5068 (ISSN-L)
  • 1421-9735
DOI
10.1159/000526995
PMC
PMC10210077
OpenAlex
W4318188457
Cited by
11
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 2
FWCI
2.13
Type
journal article
Language
en
Open access
Licence
Locations
  • Blood Purification (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Health Professions › Emergency Medical Services › Central Venous Catheters and Hemodialysis
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
Keywords
patient-reported outcomes, dialysis prescription, quality of life, survival, mortality risk factors, nutritional assessment, dietary intervention, protein adsorption, biocompatibility, pruritus, inflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review